Stentys SA

Type: Company
Name: Stentys SA
Nationality: United States
Fact Sheet: Fact Sheet for Stentys
First reported Oct 28 2014 - Updated Oct 28 2014 - 1 reports

Stentys Posts Revenue Results for the First 9 Months of 2014

Stentys reported revenues for the third-quarter and nine-months ended September 30. In a release on October 23, the company noted that it recorded revenues of EUR876.5 thousand over the third quarter of 2014, up 14.1 percent compared with the third quarter ... [Published Individual.com - Oct 28 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 2 reports

Stentys SA's Sirolimus-Eluting Stent receives CE Marking

1:50pm EDTStentys SA:Receives CE Marking for its Sirolimus-Eluting Stent (SES).CE Marking will allow the Company to market its SES in Europe immediately and, starting in 2015, in the many other countries where the company has commercial activity. ... [Published Reuters - Oct 27 2014]
Entities: Stentys SA, Stent
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

BRIEF-Stentys receives CE marking for its sirolimus-eluting stent

Oct 27 (Reuters) - Stentys SA :* Receives CE marking for its sirolimus-eluting stentSource text for Eikon:Further company coverage:(Gdynia Newsroom: +48 58 698 39 20;Gdynia.newsroom@thomsonreuters.com) ... [Published Reuters UK - Oct 27 2014]
Entities: Stent, Stentys SA
First reported Oct 23 2014 - Updated Oct 24 2014 - 1 reports

BRIEF-Stentys reports Q3 revenue of 0.88 mln euros versus 0.77 mln euros last year

Oct 23 (Reuters) - Stentys SA :* Says Q3 revenue is 0.88 million euros versus 0.77 millioneuros last yearSource text for Eikon:Further company coverage:(Gdynia Newsroom: +48 58 698 39 2 ... [Published Reuters UK - Oct 23 2014]
Entities: Stentys SA
First reported Oct 23 2014 - Updated Oct 23 2014 - 3 reports

STENTYS Revenues for the First 9 Months of 2014 up 16.9%

STENTYS , a medical technology company commercializing, in Europe, the world's first and only Self-Apposing® stent to treat acute myocardial infar ... [Published Yahoo! Finance UK and Ireland - Oct 23 2014]
First reported Oct 20 2014 - Updated Oct 21 2014 - 1 reports

STENTYS Wins Large Regional Tender in Middle East

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Wins Large Regional Tender in Middle East ... [Published Business Wire Health News - Oct 20 2014]
Entities: Stentys SA, Paris
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

BRIEF-Stentys wins tender which could be for more than 1,000 stents

Oct 20 (Reuters) - Stentys SA :* Wins SGH tender which could be for more than 1,000 stents* SGH tender is centralised purchase programme put in placeby Gulf States' Council for Cooperation* SGH tender programme is renewed each year for 12 monthsFurther ... [Published Reuters UK - Oct 20 2014]
Entities: Stent, Stentys SA
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Novel Self-Apposing Stents To Treat Coronary Heart Disease

A French medtech company has developed the first self-apposing stent to treat acute myocardial infarction. It might represent the start of a new era in the treatment of coronary heart disease. This global market is worth an estimated 2 billion dollar ... [Published European Medical Device Technology - Oct 01 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

STENTYS Reports First Half 2014 Financial Results -2-

This press release contains forward-looking statements about the Company's business. Such forward looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which it will ... [Published Scottrade - Sep 22 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 1 reports

STENTYS Stent Continues to Show Low Mortality Two Years after Treatment of a Heart Attack

PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction ... [Published EON Science - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

STENTYS Stent Continues to Show Low Mortality Two Years after Treatment of a Heart Attack

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), ... [Published Business Wire Science: Science News - Sep 16 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 3 reports

STENTYS Reaches 10,000 Self-Apposing Stent implantations

PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--STENTYS Reaches 10,000 Self-Apposing Stent implantations. ... [Published EON Science - Sep 03 2014]
Entities: Stentys SA, Stent, Paris

Quotes

Gonzague Issenmann, Chief Executive Officer and co-founder of Stentys, said, "The quarterly sales growth is progressing smoothly with our current product portfolio, as illustrated by the latest success with the regional tender in the Middlethe Middle East for 2015. We intend to pursue our sales coverage strategy in high-potential geographies by creating strong partnerships with the best local distributors."

More Content

All (30) | News (12) | Reports (0) | Blogs (17) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Coronary Stents Market (Bare Metal Stents, Drug... [Published Finwin - 13 hours ago]
Stentys Posts Revenue Results for the First 9 M... [Published Individual.com - Oct 28 2014]
Stentys SA's Sirolimus-Eluting Stent receives C... [Published Reuters - Oct 27 2014]
BRIEF-Stentys receives CE marking for its sirol... [Published Reuters UK - Oct 27 2014]
STENTYS’ Sirolimus-Eluting Stent Receives CE Ma... [Published Business Wire Health News - Oct 27 2014]
BRIEF-Stentys reports Q3 revenue of 0.88 mln eu... [Published Reuters UK - Oct 23 2014]
STENTYS Revenues for the First 9 Months of 2014... [Published Yahoo! Finance UK and Ireland - Oct 23 2014]
STENTYS Revenues for the First 9 Months of 2014... [Published Fort Mills Times - Oct 23 2014]
STENTYS Revenues for the First 9 Months of 2014... [Published Business Wire Health News - Oct 23 2014]
BRIEF-Stentys wins tender which could be for mo... [Published Reuters UK - Oct 20 2014]
STENTYS Wins Large Regional Tender in Middle East [Published Business Wire Health News - Oct 20 2014]
Novel Self-Apposing Stents To Treat Coronary He... [Published European Medical Device Technology - Oct 01 2014]
BRIEF-Stentys creates branch office in Dubai [Published Reuters UK - Sep 25 2014]
BRIEF-Stentys reports H1 net loss of 13.19 mln ... [Published Reuters UK - Sep 22 2014]
STENTYS Reports First Half 2014 Financial Resul... [Published Scottrade - Sep 22 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published EON Science - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Science: Science News - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Health News - Sep 16 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published EON Science - Sep 03 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published Business Wire Science: Science News - Sep 03 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published Business Wire Health News - Sep 03 2014]
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
STENTYS Sirolimus-Eluting Stent Demonstrates Be... [Published Business Wire Health News - May 20 2014]
STENTYS Secures a Standby Equity Facility [Published Business Wire Health News - May 14 2014]
STENTYS: Journal of the American College of Car... [Published Business Wire Health News - May 06 2014]
Fact Sheet for Stentys [Published Silobreaker - Sep 03 2010]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
STENTYS’ Sirolimus-Eluting Stent Receives CE Ma... [Published Business Wire Health News - Oct 27 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS’ Sirolimus-Eluting Stent Receives CE Marking. ...
STENTYS Revenues for the First 9 Months of 2014... [Published Business Wire Health News - Oct 23 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Revenues for the First 9 Months of 2014 up 16.9% ...
STENTYS Wins Large Regional Tender in Middle East [Published Business Wire Health News - Oct 20 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Wins Large Regional Tender in Middle East ...
STENTYS Stent Continues to Show Low Mortality T... [Published EON Science - Sep 16 2014]
PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction ...
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Science: Science News - Sep 16 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), ...
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.